Human IL-36Ra/IL-1F5 Antibody
R&D Systems, part of Bio-Techne | Catalog # MAB1275
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Met1-Asp155
Accession # Q9UBH0
Specificity
Clonality
Host
Isotype
Applications for Human IL-36Ra/IL-1F5 Antibody
Western Blot
Sample: Recombinant Human IL-36Ra/IL-1F5 (Catalog # 1275-IL)
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IL-36Ra/IL-1F5
Human interleukin 1 family member #5 [IL-1F5; also named FIL-1 delta (delta), IL-1HY1, IL-1H3, and IL-1L1] is a member of the IL-1 family of proteins (1‑5). IL-1 family members include IL-1 beta, IL-1 alpha, IL-1ra, IL-18, and IL-1F5 - IL-1F10 (6). All family members show a 12 beta-strand, beta-trefoil configuration, and all family members are believed to have arisen from a common ancestral gene that underwent multiple duplications (6). The human IL-1F5 gene is in closest proximity to the gene for IL-1ra and is likely a relatively recent duplication of the IL-1ra gene (2, 3). IL-1F5 is synthesized as a 155 amino acid (aa) protein that contains no signal sequence, no prosegment and no potential N-linked glycosylation site(s) (2‑5). Nevertheless, it appears to be secreted as a 17 kDa monomer (5). There is an alternate start site that potentially gives rise to an alternate splice form (5). The translated product, however, has a premature stop codon, resulting in a truncated 16 aa peptide. Human to mouse, full length IL-1F5 has 90% aa identity. Within the family, IL-1F5 is 50% aa identical to IL-1ra, and 32%, 31%, 35%, 37%, 32%, and 42% aa identical to IL‑1 beta, IL-1F6, F7, F8, F9, and F10, respectively. Cells reported to express IL-1F5 include monocytes, B cells, dendritic cells/Langerhans cells, keratinocytes, and gastric fundus Parietal and Chief cells (1, 7). The receptor for IL-1F5 has not been positively identified. Indirect evidence suggests it is IL-1 Rrp2 and/or IL‑1 RAcP (8). In either case, activity association with receptor binding is also unclear. It was initially reported to be an antagonist of IL-1F9 activity (4, 6). This would be consistent with its hypothesized relationship to IL-1ra. Studies, however, find IL-1F5 antagonist activity difficult to demonstrate (8).
References
- Smith, D.E. et al. (2000) J. Biol. Chem. 275:1169.
- Kumar, S. et al. (2000) J. Biol. Chem. 275:10308.
- Mulero, J.J. et al. (1999) Biochem. Biophys. Res. Commun. 263:702.
- Nicklin, M.J.H. et al. (2002) Genomics. 79:718.
- Barton, J.L. et al. (2000) Eur. J. Immunol. 30:3299.
- Dunn, E. et al. (2001) Trends Immunol. 22:533.
- Debets, R. et al. (2001) J. Immunol. 167:1440.
- Towne, J.E. et al. (2004) J. Biol. Chem. 279:13677.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional IL-36Ra/IL-1F5 Products
Product Documents for Human IL-36Ra/IL-1F5 Antibody
Product Specific Notices for Human IL-36Ra/IL-1F5 Antibody
For research use only